
    
      Patients with benign gynecologic conditions (fibroids, pelvic pain, uterine prolapse) who are
      planned to undergo laparoscopic hysterectomy will be enrolled in the study. After
      randomization, the study participants will be given 60 mg duloxetine 2 hours before surgery
      and 24 hours after surgery, whereas the control participants will be given placebo tablets.
    
  